83 related articles for article (PubMed ID: 21671479)
1. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Choe KS; Haraf DJ; Solanki A; Cohen EE; Seiwert TY; Stenson KM; Blair EA; Portugal L; Villaflor VM; Witt ME; Vokes EE; Salama JK
Cancer; 2011 Oct; 117(20):4671-8. PubMed ID: 21671479
[TBL] [Abstract][Full Text] [Related]
2. Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis.
Roesch J; Oertel M; Wegen S; Trommer M; Schleifenbaum J; Hering D; Mäurer M; Knippen S; Dobiasch S; Waltenberger M; von der Grün J; Medenwald D; Süß C; Hoeck M; Käsmann L; Fleischmann DF; Rühle A; Nicolay NH; Fabian A; Löser A; Heß S; Tamaskovics B; Vinsensia M; Hecht M;
Radiother Oncol; 2023 Apr; 181():109380. PubMed ID: 36273736
[TBL] [Abstract][Full Text] [Related]
3. Curative high-dose reirradiation for patients with recurrent head and neck adenoid cystic carcinomas: outcomes and analysis of patterns of failure.
Mahé M; Beddok A; Goudjil F; Ala Eddine C; Bolle S; Champion L; Feuvret L; Herman P; Zefkili S; Choussy O; Le Tourneau C; Dendale R; Buvat I; Sauvaget E; Créhange G; Calugaru V
Int J Radiat Biol; 2024; 100(1):79-86. PubMed ID: 37526368
[TBL] [Abstract][Full Text] [Related]
4. Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial.
Hotca A; Sindhu KK; Lehrer EJ; Hartsell WF; Vargas C; Tsai HK; Chang JH; Apisarnthanarax S; Nichols RC; Chhabra AM; Hasan S; Press RH; Lazarev S; Hajj C; Kabarriti R; Rule WG; Simone CB; Choi JI
Adv Radiat Oncol; 2024 May; 9(5):101459. PubMed ID: 38596455
[TBL] [Abstract][Full Text] [Related]
5. Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach-part I: prognostic factors and indications to treatment.
Alterio D; Zaffaroni M; Bossi P; Dionisi F; Elicin O; Falzone A; Ferrari A; Jereczek-Fossa BA; Sanguineti G; Szturz P; Volpe S; Scricciolo M
Radiol Med; 2024 Jan; 129(1):160-173. PubMed ID: 37731151
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in head and neck cancer: a 10-year retrospective analysis in a single-institution in Italy.
Cadoni G; Giraldi L; Petrelli L; Pandolfini M; Giuliani M; Paludetti G; Pastorino R; Leoncini E; Arzani D; Almadori G; Boccia S
Acta Otorhinolaryngol Ital; 2017 Dec; 37(6):458-466. PubMed ID: 28663597
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation for locoregionally recurrent non-small cell lung cancer.
Vyfhuis MAL; Rice S; Remick J; Mossahebi S; Badiyan S; Mohindra P; Simone CB
J Thorac Dis; 2018 Aug; 10(Suppl 21):S2522-S2536. PubMed ID: 30206496
[TBL] [Abstract][Full Text] [Related]
8. Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy.
Xiao C; Hanlon A; Zhang Q; Ang K; Rosenthal DI; Nguyen-Tan PF; Kim H; Movsas B; Bruner DW
Oral Oncol; 2013 Apr; 49(4):360-6. PubMed ID: 23168337
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer: improving outcomes with a multidisciplinary approach.
Lo Nigro C; Denaro N; Merlotti A; Merlano M
Cancer Manag Res; 2017; 9():363-371. PubMed ID: 28860859
[TBL] [Abstract][Full Text] [Related]
10. Proton Reirradiation for High-Risk Recurrent or New Primary Breast Cancer.
Chakraborty MA; Khan AJ; Cahlon O; Xu AJ; Braunstein LZ; Powell SN; Choi JI
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136268
[TBL] [Abstract][Full Text] [Related]
11. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.
Cohen EE; Karrison TG; Kocherginsky M; Mueller J; Egan R; Huang CH; Brockstein BE; Agulnik MB; Mittal BB; Yunus F; Samant S; Raez LE; Mehra R; Kumar P; Ondrey F; Marchand P; Braegas B; Seiwert TY; Villaflor VM; Haraf DJ; Vokes EE
J Clin Oncol; 2014 Sep; 32(25):2735-43. PubMed ID: 25049329
[TBL] [Abstract][Full Text] [Related]
12. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Seiwert TY; Darga T; Haraf D; Blair EA; Stenson K; Cohen EE; Salama JK; Villaflor V; Witt ME; Lingen MW; Weichselbaum RR; Vokes EE
Ann Oncol; 2013 Mar; 24(3):769-76. PubMed ID: 23104721
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Pederson AW; Salama JK; Haraf DJ; Witt ME; Stenson KM; Portugal L; Seiwert T; Villaflor VM; Cohen EE; Vokes EE; Blair EA
Head Neck Oncol; 2011 Jul; 3():31. PubMed ID: 21791072
[TBL] [Abstract][Full Text] [Related]
14. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
[TBL] [Abstract][Full Text] [Related]
15. Reply to s. Chakraborty et al.
Cohen EE; Kocherginsky M; Karrison T; Seiwert TY; Haraf DJ; Brockstein B; Vokes EE
J Clin Oncol; 2015 Mar; 33(8):968. PubMed ID: 25667282
[No Abstract] [Full Text] [Related]
16. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.
Fakhry C; Zhang Q; Nguyen-Tan PF; Rosenthal D; El-Naggar A; Garden AS; Soulieres D; Trotti A; Avizonis V; Ridge JA; Harris J; Le QT; Gillison M
J Clin Oncol; 2014 Oct; 32(30):3365-73. PubMed ID: 24958820
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck.
Perez CA; Song H; Raez LE; Agulnik M; Grushko TA; Dekker A; Stenson K; Blair EA; Olopade OI; Seiwert TY; Vokes EE; Cohen EE
Oral Oncol; 2012 Sep; 48(9):887-92. PubMed ID: 22513208
[TBL] [Abstract][Full Text] [Related]
18. Chemoradiation for patients with large-volume laryngeal cancers.
Stenson KM; Maccracken E; Kunnavakkam R; W Cohen EE; Portugal LD; Villaflor V; Seiwert T; Blair E; Haraf DJ; Salama JK; Vokes EE
Head Neck; 2012 Aug; 34(8):1162-7. PubMed ID: 22052816
[TBL] [Abstract][Full Text] [Related]
19. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
20. A comparative dose-escalation analysis for reirradiated cancer patients with and without appropriate dose mapping.
Sarkar B; Biswal SS; Shahid T; Appunu K; Bhattacharya J; Ganesh T; Munshi A; Das A
Radiat Environ Biophys; 2024 Mar; 63(1):71-80. PubMed ID: 38078988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
